Enhanced levels of double-strand DNA break repair proteins protect ovarian cancer cells against genotoxic stress-induced apoptosis

Journal of Ovarian Research

Volumn 6, Issue 1, 2013, Pages

  Kalra, Rajkumar Singh ^a   Bapat, Sharmila A ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Aneuploidy; DSB repair; HR and NHEJ pathways; SeOvCa progression model

Indexed keywords

CISPLATIN; DOUBLE STRANDED DNA BREAK REPAIR PROTEIN; ESTRADIOL; MEMBRANE PROTEIN; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FRAGMENTATION; DOUBLE STRANDED DNA BREAK; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; GENOTOXICITY; GIEMSA STAIN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALIGNANT TRANSFORMATION; MODULATION; MORPHOLOGY; NICK END LABELING; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINDLE CELL; VALIDATION PROCESS;

EID: 84883858755     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-6-66     Document Type: Article

References (29)

1. Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Zhou BB, Bartek J, Nat Rev Cancer 2004 4 216 25 10.1038/nrc1296 14993903 (Pubitemid 38337501)
2. Cell-cycle checkpoints and cancer. Kastan MB, Bartek J, Nat 2004 432 316 323 10.1038/nature03097 (Pubitemid 39551659)
3. Integrated genomic analyses of ovarian carcinoma. Berchuk CGARN, Nature 2011 474 609 615 10.1038/nature10166 21720365
4. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD, Nature 2005 434 907 913 10.1038/nature03485 15829965 (Pubitemid 40559004)
5. An oncogene-induced DNA damage model for cancer development. Halazonetis TD, Gorgoulis VG, Bartek J, Sci 2008 319 1352 1355 10.1126/science.1140735 (Pubitemid 351354863)
6. Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer. Kalra RS, Bapat SA, PLoS ONE 2013 8 8 70398 10.1371/journal.pone.0070398 23936423
7. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Bapat SA, Mali AM, Koppikar CB, Kurrey NK, Cancer Res 2005 65 3025 3029 15833827 (Pubitemid 40524578)
8. Hallmarks of cancer: the next generation. Hanahan D, Weinberg RA, Cell 2011 144 646 674 10.1016/j.cell.2011.02.013 21376230
9. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. Wu MH, Yung BY, J Biol Chem 2002 277 48234 48240 10.1074/jbc.M206550200 12374805 (Pubitemid 35470775)
10. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC, Helin K, Falini B, Pelicci PG, Mol Cell Biol 2005 25 8874 8886 10.1128/MCB.25.20.8874-8886.2005 16199867 (Pubitemid 41429079)
11. Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates. Koike A, Nishikawa H, Wu W, Okada Y, Venkitaraman AR, Ohta T, Cancer Res 2010 70 6746 6756 10.1158/0008-5472.CAN-10- 0382 20713529
12. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Franco S, Gostissa M, Zha S, Lombard DB, Murphy MM, Zarrin AA, Yan C, Tepsuporn S, Morales JC, Adams MM, Lou Z, Bassing CH, Manis JP, Chen J, Carpenter PB, Alt FW, Mol Cell 2006 21 2 201 214 10.1016/j.molcel.2006.01.005 16427010 (Pubitemid 43099936)
13. Differential usage of onhomologous end-joining and homologous recombination in double strand break repair. Sonoda E, Hochegger H, Saberi A, Taniguchi Y, Takeda S, DNA Repair 2006 5 1021 1029 10.1016/j.dnarep.2006.05.022 16807135 (Pubitemid 44291617)
14. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Hopfner KP, Craig L, Moncalian G, Zinkel RA, Usui T, Owen BA, Karcher A, Henderson B, Bodmer JL, McMurray CT, Carney JP, Petrini JH, Tainer JA, Nature 2002 418 562 566 10.1038/nature00922 12152085 (Pubitemid 34851405)
15. Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. Boulton SJ, Jackson SP, EMBO J 1998 17 819 828
16. Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Wani AA, Sharma N, Shouche YS, Bapat SA, Oncogene 2006 25 6336 6344 10.1038/sj.onc.1209649 16732329 (Pubitemid 44564749)
17. Preparation of RNA from tissues and cells. Ribaudo R, Gilman M, Kingston RE, Choczynski P, Sacchi N, Curr Protoc Immunol 2001 10 10 11 18432674
18. Snail and Slug mediate radio- and chemo-resistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, Bapat SA, Stem Cells 2009 27 2059 2068 10.1002/stem.154 19544473
19. CREBBP re-arrangements affect protein function and lead to aberrant neuronal differentiation. Sharma N, Jadhav SP, Bapat SA, Differentiation 2010 79 218 231 10.1016/j.diff.2010.02.001 20207472
20. Gene expression: protein interaction systems network modeling identifies transformation-associated molecules and pathways in ovarian cancer. Bapat SA, Krishnan A, Ghanate AD, Kusumbe AP, Kalra RS, Cancer Res 2010 70 4809 4819 10.1158/0008-5472.CAN-10-0447 20530682
21. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B, Proc Natl Acad Sci U S A 2003 8 164 8169
22. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Dubik D, Dembinski TC, Shiu RP, Cancer Res 1987 47 6517 6521 3677090 (Pubitemid 18019647)
23. Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. Dubik D, Shiu RP, J Biol Chem 1988 263 12705 12708 3045126 (Pubitemid 19000455)
24. Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Eastman A, Barry MA, Biochem 1987 26 3303 3307 10.1021/bi00386a009 (Pubitemid 17113661)
25. Nucleophosmin regulates the stability and transcriptional activity of p53. Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG, Nat Cell Biol 2002 4 529 533 10.1038/ncb814 12080348 (Pubitemid 34752440)
26. Specific phosphorylation of nucleophosmin on Thr199 by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K, J Bio Chem 2001 276 21529 21537 10.1074/jbc.M100014200
27. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD, J Pathol 2010 221 49 56 10.1002/path.2696 20229506
28. The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome. Wojnarowicz PM, Oros KK, Quinn MC, Arcand SL, Gambaro K, Madore J, Birch AH, de Ladurantaye M, Rahimi K, Provencher DM, Mes-Masson AM, Greenwood CM, Tonin PN, PLoS One 2012 7 45484 10.1371/journal.pone.0045484 23029043
29. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma: evidence supporting the clonal relationship of the two lesions. Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R, Wang TL, Shih Ie M, J Pathol 2012 226 421 426 10.1002/path.3023 21990067